請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52860
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山(Jean-San Chia) | |
dc.contributor.author | Kuan-Wei Su | en |
dc.contributor.author | 蘇冠瑋 | zh_TW |
dc.date.accessioned | 2021-06-15T16:31:04Z | - |
dc.date.available | 2015-09-24 | |
dc.date.copyright | 2015-09-24 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-13 | |
dc.identifier.citation | 1. Kamangar F, Dores, G. M. & Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.
2. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24(10):450-3. 3. Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39(3):207-12. 4. Pagedar NA, Gilbert RW. Selective neck dissection: a review of the evidence. Oral Oncol. 2009;45(4-5):416-20. 5. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4(6):448-56. 6. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer. 1992;70(1):14-9. 7. Chen MC, Chen PT, Chan CH, Yang CT, Chen CC, Huang CE, et al. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. Journal of cancer research and clinical oncology. 2011;137(1):115-23. 8. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA: a cancer journal for clinicians. 1994;44(1):7-26. 9. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 1995;79(3):321-9. 10. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem. 1997;272(9):5846-53. 11. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol. 1997;158(3):1033-6. 12. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood. 1997;89(9):3315-22. 13. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem. 1997;272(23):14893-8. 14. Zhao L, Xia J, Wang X, Xu F. Transcriptional regulation of CCL20 expression. Microbes Infect. 2014;16(10):864-70. 15. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine & Growth Factor Reviews. 2003;14(5):409-26. 16. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. The Journal of experimental medicine. 1997;186(6):837-44. 17. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, Romani N, et al. Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function. Experimental dermatology. 2002;11(2):135-42. 18. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. The Journal of experimental medicine. 2000;192(5):705-18. 19. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol. 2000;164(12):6621-32. 20. Marsigliante S, Vetrugno C, Muscella A. CCL20 induces migration and proliferation on breast epithelial cells. Journal of cellular physiology. 2013;228(9):1873-83. 21. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. The Journal of experimental medicine. 1999;190(12):1755-68. 22. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-52. 23. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(12):1910-6. 24. Ghadjar P, Rubie C, Aebersold DM, Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. International journal of cancer Journal international du cancer. 2009;125(4):741-5. 25. Takahashi K, Nakanishi T, Yumoto H, Adachi T, Matsuo T. CCL20 production is induced in human dental pulp upon stimulation by Streptococcus mutans and proinflammatory cytokines. Oral microbiology and immunology. 2008;23(4):320-7. 26. Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clinical and experimental immunology. 2001;125(1):155-61. 27. Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. International immunology. 2001;13(1):95-103. 28. Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer journal. 2004;10(6):374-80. 29. Abiko Y, Nishimura M, Kusano K, Nakashima K, Okumura K, Arakawa T, et al. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma. Archives of oral biology. 2003;48(2):171-5. 30. Chang KP, Kao HK, Yen TC, Chang YL, Liang Y, Liu SC, et al. Overexpression of macrophage inflammatory protein-3alpha in oral cavity squamous cell carcinoma is associated with nodal metastasis. Oral Oncol. 2011;47(2):108-13. 31. Wang GZ, Cheng X, Li XC, Liu YQ, Wang XQ, Shi X, et al. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. Cancer letters. 2015;363(1):60-70. 32. Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World journal of gastroenterology : WJG. 2015;21(2):475-83. 33. Zeng W, Chang H, Ma M, Li Y. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production. Experimental and molecular pathology. 2014;97(1):184-90. 34. Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. European journal of cancer. 2010;46(9):1712-23. 35. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nature reviews Immunology. 2006;6(4):295-307. 36. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-87. 37. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nature reviews Immunology. 2010;10(7):490-500. 38. Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood. 2006;108(2):426-31. 39. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature medicine. 2004;10(9):942-9. 40. Chen KJ, Lin SZ, Zhou L, Xie HY, Zhou WH, Taki-Eldin A, et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PloS one. 2011;6(9):e24671. 41. Chen B, Zhang D, Zhou J, Li Q, Zhou L, Li SM, et al. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma. Oncology reports. 2013;30(3):1380-90. 42. Jin S, DiPaola RS, Mathew R, White E. Metabolic catastrophe as a means to cancer cell death. Journal of cell science. 2007;120(Pt 3):379-83. 43. Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bulletin du cancer. 2006;93(8):E73-80. 44. Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics. 2004;84(6):1014-20. 45. Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, Lopez-Alemany R. alpha-Enolase, a multifunctional protein: its role on pathophysiological situations. Journal of biomedicine & biotechnology. 2012;2012:156795. 46. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clinical & experimental metastasis. 2002;19(4):319-26. 47. Mahmoud S, Lee A, Ellis I, Green A. CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker? Oncoimmunology. 2012;1(3):364-5. 48. Lee JJ, Chang YL, Lai WL, Ko JY, Kuo MY, Chiang CP, et al. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head & neck. 2011;33(9):1301-8. 49. Tsai FC, Seki A, Yang HW, Hayer A, Carrasco S, Malmersjo S, et al. A polarized Ca2+, diacylglycerol and STIM1 signalling system regulates directed cell migration. Nature cell biology. 2014;16(2):133-44. 50. Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, et al. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2012;16(4):828-36. 51. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7. 52. Campbell AS, Albo D, Kimsey TF, White SL, Wang TN. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. The Journal of surgical research. 2005;123(1):96-101. 53. Muraoka K, Okumura K, Kitajo H, Kato H, Arisue M. Chemokine Receptor Expression in Oral Squamous Cell Carcinoma : Correlation with Growth Factor- and Cytokine-mediated Cell Migration in vitro. Oral Science International. 2007;4(2):73-85. 54. Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer research. 2004;64(5):1861-6. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52860 | - |
dc.description.abstract | 「CC趨化因子20」(CCL20)是屬於「CC趨化因子家族」的一種細胞因子。它目前唯一知道的受體為「CC趨化因子受體6」(CCR6)。最近越來越多的研究發現在人類癌症中有CCL20的過度表現,而這種現象與腫瘤發炎微環境有關。另外在「人類調節性T細胞」(Treg)當中有特殊的一群Treg細胞會表現CCR6,而這群Treg細胞會受到CCL20的吸引跑到腫瘤位。因此腫瘤位的免疫反應因此被抑制而促進腫瘤的發展。此外在一些癌症當中CCL20與CCR6的活化能促進癌細胞的轉移能力。除此之外CCL20還能吸引表現CCR6的淋巴細胞。α-烯醇酶 (α-enolase) (ENO1) 常在不同種類的癌症當中被發現過度表現,並且與CCL20的表現有關。因此本篇主要想探討的是:在臨床上CCL20、Foxp3 T細胞、CD8 T細胞以及ENO1之間的關聯性。另外還要探討CCL20對口腔癌細胞轉移能力的影響。在本篇的實驗當中我們收集臨床口腔癌症病患的組織,進行冷凍切片後利用免疫組織化學染色法染色。除此之外我們還發現發炎因子:「脂多醣體」(LPS)與「腫瘤壞死因子-α」(TNF-α)能促進口腔癌細胞株:SAS, HSC-3以及Ca9-22表現以及分泌CCL20。最後我們利用CCL20作為吸引員並發現口腔癌細胞能被CCL20所吸引並進行轉移。因為CCL20與CCR6互為彼此唯一的配體與受體,因此了解CCL20與CCR6在口腔癌轉移當中扮演的角色或許能提供治療口腔癌症病患一些新想法。 | zh_TW |
dc.description.abstract | CCL20 is a member of the CC-chemokine family and its sole receptor is known as CC chemokine receptor 6 (CCR6). There were elevated CCL20 expression reported in variety of human cancers, which may contributed to inflammatory microenvironment in tumor site. Interestingly, there is a unique subtype of regulatory T cells (Tregs) which specifically express CCR6. Admittedly, CCR6+ Foxp3+Tregs can be attracted by CCL20 to the tumor site. This phenomenon may cause immunity suppression, hence promotes tumor progression. Furthermore, CCL20 also known to attract lymphocytes which express CCR6. α-enolase (ENO1) is an enzyme often overexpressed in various cancer, and it is positively correlated to CCL20 expression. In addition, CCL20/CCR6 interaction could increase the migration ability in some cancers. This study aimed to investigate the relationship between CCL20, Foxp3+ regulatory T cells, CD8+ T cells, ENO1 and clinical characteristics of oral cancer patients. We also aimed to study the effect of CCL20 on migration ability of oral cancer cell lines. In present study, we collected clinical oral cancer patients and performed immunohistochemistry staining of CCL20 and Foxp3. Moreover, we found that LPS and TNF-α, represented as inflammatory stimuli, could stimulate CCL20 expressing and releasing in human oral cancer cell lines: SAS, HSC-3 and Ca9-22 cells. Furthermore, we found that oral cancer cell lines had chemotactic response to CCL20. Due to CCL20 and CCR6 are the only ligand and receptor for each other, it is innovative to understand their role in oral cancer progression. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T16:31:04Z (GMT). No. of bitstreams: 1 ntu-104-R02450016-1.pdf: 7066574 bytes, checksum: b30836add6a92c1c8b1b77d87fe4babc (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | Acknowledgement 4
口試委員會論文審定書 5 Abstract 6 中文摘要 8 Chapter 1: Introduction 9 1-1 Oral cancer 9 1-2 Chemokine ligand 20 11 1-3 Chemokine ligand 20 and human diseases 12 1-4 Chemokine ligand 20 expression in oral disease 14 1-5 Chemokine ligand 20 promotes tumor cells migration and invasion 14 1-6 Chemokine ligand 20 and Regulatory T cells 15 1-7 Chemokine ligand 20 and α-enolase 16 Chapter 2: Hypothesis and specific aims 19 Chapter 3: Materials and Methods 20 3-1 Tissue specimens 20 3-2 Immunohistochemistry Staining 20 3-2-1 Staining procedure 20 3-2-2 Quantitative analysis 21 3-3 Cell lines and Cell Culture 22 3-3-1 Human oral cancer cell line 22 3-3-2 Cell stimulation 22 3-4 Isolation of RNA, reverse transcription PCR and Real-time PCR analysis 23 3-4-1 RNA extraction 23 3-4-2 Reverse transcription 24 3-4-3 Reverse transcription PCR and Real-time PCR analysis 24 3-5 Enzyme Linked Immunosorbent Assay 25 3-6 Wound-healing assay 26 3-7 Migration assay 27 3-8 MTT assay 27 3-9 Statistical analysis 28 Chapter 4: Results 29 4-1 CCL20 is highly expressed in tumor cells of oral cancer patients 29 4-2 Correlation of CCL20 expression with clinicopathological characteristics 29 4-3 Proinflammatory cytokines induce the expression of CCL20 in oral cancer cells 31 4-4 CCL20 increases the migration ability of oral cancer cell lines in vitro 32 Chapter 5: Discussion 35 Chapter 6: References 38 Chapter 7: Table 47 Table 1. The clinicopathological characteristics of OSCCs. 47 Table 2. Correlation between CCL20, Foxp3, CD8, Enolase1 and clinical characteristics 48 Table 3. Primer sequences used in this study 49 Chapter 8: Figures 50 Figure 1. CCL20, Foxp3, CD8 and ENO1 expressions in OSCC 52 Figure 2. Overexpression of CCL20 in OSCC tissues 53 Figure 3. Overexpression of CCL20 predicts poor survival in OSCC patients 55 Figure 4. TNF-α and LPS induced the expression of CCL20 in SAS cells 57 Figure 5. TNF-α and LPS induced the expression and secretion of CCL20 in Oral cancer cell lines. 59 Figure 6. CCL20 increased SAS cells and HSC-3 cells migration 61 Figure 7. CCL20 enhanced SAS cells and HSC-3 cells migration using transwell 64 Figure 8. SAS cells and HSC-3 cells showed chemotactic response to CCL20. 67 | |
dc.language.iso | en | |
dc.title | 發炎因子在人類口腔癌誘導CCL20表現並吸引淋巴細胞或促使口腔癌細胞轉移 | zh_TW |
dc.title | Inflammatory cytokines induce CCL20 expression caused lymphocytes recruitment or promote oral cancer cells migration | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李正?(Jang-Jaer Lee),張玉芳(Yu-Fong Chang) | |
dc.subject.keyword | CCL20,CCR6,發炎因子,轉移,口腔癌, | zh_TW |
dc.subject.keyword | CCL20,CCR6,inflammatory cytokines,migration,oral cancer, | en |
dc.relation.page | 67 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-13 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 6.9 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。